2026-01-15 - Analysis Report
### Simple Numbers

* Cumulative return of review stock (ACN): **0.88%**
* Cumulative return of comparison stock (S&P 500, VOO): **93.94%**
* Divergence (current): **-93.10**
* Relative divergence: **7.90%**
* 5-day SMA: **$278.85**
* 20-day SMA: **$272.44**
* 60-day SMA: **$258.56**
* Close price: **$276.80**
* Last-market price: **$290.62**
* Change: **4.99%**
* RSI: **56.81**
* PPO: **0.11**
* MRI: **0.70**
* Expected Return: **-236.20%**
* Analysts' opinions:
  + Key: **Buy**
  + Mean rating: **2.07 (~Buy)**
  + Opinions: **26**
  + Average Target Price: **$290.59**
  + Target Price (avg/high/low): **$290.59 / $330.00 / $210.00**
* EPS (2025-12-18): **$3.57**
* Revenue (2025-12-18): **$18.74B**
* Profit Margin (2025-11-30): **33.07%**
* ROE (2025-11-30): **7.16%**
* Equity (2025-11-30): **$30.87B**

### Simple Analysis

#### Return Rate Comparison

The cumulative return of the review stock ACN is **0.88%**, while the comparison stock S&P 500 is **93.94%**. The divergence is **-93.10**, indicating a significant difference in performance.

#### Stock Price Fluctuation

The recent stock price fluctuations show a 5-day SMA of **$278.85**, a 20-day SMA of **$272.44**, and a 60-day SMA of **$258.56**. The close price is **$276.80**, and the last-market price is **$290.62** with a change of **4.99%**.

#### Risk and Return Indicators

The RSI is **56.81**, indicating that the stock is neither overbought nor oversold. The PPO is **0.11**, and the MRI is **0.70**, indicating a medium investment risk. The hybrid signal is **Buy** with **0% Cash**.

#### Expected Return and Ranks

The expected return is **-236.20%**, indicating a high risk of the stock performing poorly. The 7-day rank change is **0**, and the 7-day dynamic expected return change is **0.00**.

#### Analyst Opinions and Expected Returns

Analysts have a **Buy** consensus with a mean rating of **2.07 (~Buy)** and an average target price of **$290.59**. The expected return is **-236.20%**, indicating a high risk of the stock performing poorly.

#### Recent News and Events

Recent news and events include articles about Accenture's investment attention, valuation check, and price target updates by analysts.

#### Earnings Analysis

The company has reported EPS of **$3.57** and revenue of **$18.74B** for the quarter ending December 2025.

#### Financial Information

Revenue and profitability:
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-11-30 | $18.74B | 33.07% |
| 2025-08-31 | $17.60B | 31.89% |
| 2025-05-31 | $17.73B | 32.87% |
| 2025-02-28 | $16.66B | 29.86% |
| 2024-11-30 | $17.69B | 32.92% |

Capital and profitability:
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-11-30 | $30.87B | 7.16% |
| 2025-08-31 | $31.20B | 4.53% |
| 2025-05-31 | $30.55B | 7.19% |
| 2025-02-28 | $29.25B | 6.11% |
| 2024-11-30 | $29.19B | 7.81% |

### Comprehensive Analysis

Accenture (ACN) has a review stock return rate of **0.88%**, significantly lower than the comparison stock S&P 500's **93.94%** return rate. The stock price has shown recent fluctuations with a 5-day SMA of **$278.85**, a 20-day SMA of **$272.44**, and a 60-day SMA of **$258.56**.

Risk and return indicators show a **Medium** investment risk with a **MRI** of **0.70** and a **Hybrid** signal of **Buy** with **0% Cash**. The expected return is **-236.20%**, indicating a high risk of the stock performing poorly.

Analysts have a **Buy** consensus with a mean rating of **2.07 (~Buy)** and an average target price of **$290.59**.

The company has reported strong revenue and profitability in recent quarters, with a **Revenue** of **$18.74B** and a **Profit Margin** of **33.07%** for the quarter ending November 2025.

Overall, the analysis suggests a cautious approach to investing in Accenture (ACN) due to its lower return rate and high risk of poor performance.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.